Michaël Thy, Jean-François Timsit, & Etienne de Montmollin. (2023). Aminoglycosides for the Treatment of Severe Infection Due to Resistant Gram-Negative Pathogens. MDPI AG.
Chicago Style (17th ed.) CitationMichaël Thy, Jean-François Timsit, and Etienne de Montmollin. Aminoglycosides for the Treatment of Severe Infection Due to Resistant Gram-Negative Pathogens. MDPI AG, 2023.
MLA (9th ed.) CitationMichaël Thy, et al. Aminoglycosides for the Treatment of Severe Infection Due to Resistant Gram-Negative Pathogens. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.